Masticlox DC
Masticlox DC
Authorised
- Cloxacillin hemibenzathine
- Ampicillin trihydrate
Product identification
Medicine name:
Мастиклокс DC
Masticlox DC
Active substance:
- Cloxacillin hemibenzathine
- Ampicillin trihydrate
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin hemibenzathine600.00milligram(s)1.00Syringe
-
Ampicillin trihydrate300.00milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (dry cow)
-
Meat and offal28day
-
Milk54dayМляко: 49 дни плюс 156 часа. Не се разрешава за употреба при крави с къс сухостоен период, по-кратък от 49 дни. Да не се прилага в рамките на 49 дни преди очакваната дата на раждане. Млякото от третираните крави, предназначено за консумация от хора, може да се използва 156 часа след след раждането
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RC20
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Asklep-Pharma OOD
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
Responsible authority:
- Bulgarian Agency For Food Safety
Authorisation number:
- 0022-1398
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 10/06/2022
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 10/06/2022
How useful was this page?: